Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 87.45
-1.55 (-1.74%)
Mar 24, 2026, 5:29 PM CET
Vitrolife AB Revenue
In the year 2025, Vitrolife AB had annual revenue of 3.44B SEK, down -4.68%. Vitrolife AB had revenue of 891.00M in the quarter ending December 31, 2025, a decrease of -7.09%.
Revenue
3.44B
Revenue Growth
-4.68%
P/S Ratio
3.50
Revenue / Employee
2.99M
Employees
1,151
Market Cap
12.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | -169.00M | -4.68% |
| Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Elekta AB | 17.11B |
| Nolato AB | 9.46B |
| Sectra AB | 3.52B |
| MedCap AB | 2.11B |
| BICO Group AB | 1.50B |
| Xvivo Perfusion AB | 812.17M |
| CellaVision AB | 748.45M |
Vitrolife AB News
- 7 weeks ago - Vitrolife AB (publ) - Fourth quarter and full year report 2025 - PRNewsWire
- 2 months ago - Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025 - PRNewsWire
- 5 months ago - Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026 - PRNewsWire